The Brazilian Health Regulatory Agency, ANVISA (Agência Nacional de Vigilância Sanitária), has approved PTC Therapeutics' Waylivra (volanesorsen) as the first treatment for familial partial lipodystrophy (FPL) in Brazil. This...

View the Online Magazine

Launches

Peli BioThermal launches Crēdo™ Go cold chain shipping solution

Peli BioThermal, the life science industry’s partner from discovery to distribution, announces its newest reusable, flexible temperature controlled shipping solution. Crēdo™ Go is designed...

ACG to launch German process laboratory in 2023

Following the success of its first-to-market laboratory for process development in India, ACG (the world’s biggest integrated pharmaceutical and nutraceutical manufacturing solutions provider), is...

Beckman Coulter partners with Smart4Diagnostics to close the data gap between blood collection and lab analysis

Beckman Coulter, a global clinical diagnostics leader, has announced a new partnership with Germany-based company Smart4Diagnostics to close the preanalytical data gap between blood...

Suppliers Guide

Check out our Suppliers Guide or contact our team and get your company listed

Subscribe

Keep up with what's happening in the industry and subscribe to our weekly newsletter

Events

Get your event seen by potential candidates on the world's leading industry site.

Supply Chain

ACG: “The global pharmaceutical solutions company on a mission to help manufacturers keep their supply chains moving”

The current crisis in Europe has led to increasing energy insecurity and shortages of raw materials, which are creating severe pharmaceutical manufacturing supply line...

Advanco partners with Vantage to deliver the first interoperable pharmaceutical traceability solution

Advanco, one of the globe’s leading pharmaceutical track and trace solution providers, has announced the launch of ARC/QU4RTET, the pharmaceutical sector’s first open, interoperable,...

Shionogi signs agreement with NHS England to begin innovative subscription payment model for reimbursement of its antibiotic, Fetcroja (Cefiderocol)

Shionogi & Co., Ltd. and its European subsidiary, Shionogi B.V. (hereafter "Shionogi"), today announced that Shionogi B.V. had signed an agreement with NHS England...

Lupin Healthcare announces availability of the first carbon neutral pMDI with Luforbec® 100/6 (beclometasone 100 mcg / formoterol 6 mcg) and establishes commitment to...

Lupin Healthcare, the UK-based wholly owned subsidiary of Lupin Limited (Lupin), has announced that Luforbec (beclomethasone / formoterol) 100/6 pressurised metered dose inhaler (pMDI)...

Approvals

Brazilian regulatory authority grants approval for Waylivra for familial partial lipodystrophy

The Brazilian Health Regulatory Agency, ANVISA (Agência Nacional de Vigilância Sanitária), has approved PTC Therapeutics' Waylivra (volanesorsen) as the first treatment for familial partial...

Bharat Biotech’s intranasal COVID-19 vaccine receives primary series and heterologous booster approval in India

Bharat Biotech International Limited's iNCOVACC (BBV154) has received approval from India's Central Drugs Standard Control Organisation (CDSCO) under Restricted Use in Emergency Situation for ages...

Manufacturiung

Finance

Research & Development
Latest

MS patients could be offered stem cell transplants as a first-line treatment in new world-first trial

A world-first trial is investigating if stem cell transplantation could be used in patients with aggressive multiple sclerosis (MS) as a first-line treatment. The study...

Biocytogen enters into antibody agreement with ADC Therapeutics

Biocytogen Pharmaceuticals has entered into an evaluation and option agreement with ADC Therapeutics. Biocytogen will grant ADC Therapeutics a license to evaluate its proprietary...

C4XD signs exclusive global licence worth up to $402m with AstraZeneca for development and commercialisation of NRF2 Activator programme

C4X Discovery Holdings plc (C4XD), a drug discovery company, has signed an exclusive worldwide licensing agreement with AstraZeneca worth up to $402 million, for...

£20m research boost to help develop new obesity treatments

Cutting-edge obesity treatments and technologies which can help people shed 20% of their weight could soon be offered to NHS patients thanks to a...

WHO recommends new name for monkeypox disease

Following a series of consultations with global experts, WHO will begin using a new preferred term “mpox” as a synonym for monkeypox. Both names...

Appointments